In the BioHarmony Drug Report Database
Rosuvastatin
Crestor, Ezallor Sprinkle (rosuvastatin) is a small molecule pharmaceutical. Rosuvastatin was first approved as Crestor on 2003-08-12. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. Crestor’s patents are valid until 2036-02-12 (FDA).
Trade Name
|
Crestor, Ezallor Sprinkle |
|---|---|
Common Name
|
rosuvastatin |
ChEMBL ID
|
CHEMBL1496 |
Indication
|
coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia |
Drug Class
|
Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein)